In 1972, Eurofarma started its path manufacturing drugs to third parties, national and international laboratories. As the years went by and with the increase of market perception, production capacity, equipment technology and the strict quality control adopted, the company grew. It acquired new companies and started to manufacture and market its own brands and under multinational license.
,It is currently the third greatest national capital
pharmaceutical group in Brazil and, according to Grupemef (Group of Pharmaceutical Industry Executive Professionals),
it is one of the five greatest pharmaceutical laboratories in the country. It produces and markets drugs for human and veterinary use, by means of eight business divisions: Pharma (Medical Prescription), Hospital, Generic Drugs, Oncology, Pearson (Veterinary), Third Parties, Export, and Euroglass. Thus, it has a complete line of products which cover several pathologies, acting both in the fight and prevention against various diseases.
